Home » Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

*This chart includes COVID-19 diagnostics featured in BioWorld MedTech. It was updated through March 2021. For more details about COVID-19 therapeutics and vaccines, diagnostics and clinical trial delays, go to BioWorld Snapshots.

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

Today's news in brief

Today's news in brief

Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly

J&J’s Ottava robotic system approved for US pivotal trial

GLP-1s push into MASH as semaglutide 2.4 mg hits endpoints